EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development

Melissa A Hale, Kameron Bates, Marina Provenzano, Nicholas E Johnson iD

Human Molecular Genetics · 2023

DOI: 10.1093/hmg/ddac254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Melissa A Hale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Myotonic Dystrophy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NINDS NIH HHS, CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic dystrophy type 1 (DM1) is a multi-systemic disorder caused by expansion of CTG microsatellite repeats within DMPK. The most severe form, congenital myotonic dystrophy (CDM), has symptom onset at birth due to large intergenerational repeat expansions. Despite a common mutation, CDM individuals present with a distinct clinical phenotype and absence of common DM1 symptoms. Given the clinical divergence, it is unknown if the hallmark of DM1 pathology, dysregulation of alternative splicing (AS) due to sequestration of MBNL proteins within toxic CUG repeat RNAs, contributes to disease throughout pediatric development. To evaluate global transcriptomic dysregulation, RNA-seq was performed on 36 CDM skeletal muscle biopsies ages 2 weeks to 16 years, including two longitudinal samples. Fifty DM1 and adult/pediatric controls were also sequenced as comparative groups. Despite a large CTG expansion and shared age of onset, CDM individuals presented with a heterogenous, MBNL-dependent mis-splicing signature. Estimation of intracellular MBNL concentrations from splicing responses of select events correlated with total spliceopathy and revealed a distinct, triphasic pattern of AS dysregulation across pediatric development. CDM infants (< 2 years) possess severe mis-splicing that significantly improves in early childhood (2–8 years) independent of sex or CTG repeat load. Adolescent individuals (8–16 years) stratified into two populations with a full range of global splicing dysregulation. DMPK expression changes correlated with alterations in splicing severity during development. This study reveals the complex dynamics of the CDM muscle transcriptome and provides insights into new therapeutic strategies, timing of therapeutic intervention, and biomarker development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myotonic DystrophyChild, PreschoolHumansTranscriptomeMyotonin-Protein KinaseMuscle, SkeletalRNA SplicingTrinucleotide Repeat Expansion

Substanzen

Myotonin-Protein Kinase

Autor:innen und Institutionen

  • Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.

ORCID-Profile: Nicholas E Johnson

Förderung

  • NCATS NIH HHS
  • NINDS NIH HHS
  • CDC HHS
  • FDA HHS
  • NCBDD CDC HHS
  • NIH HHS
  • University of Rochester for the CCMDHI and CMTHI
  • AMO Pharma

Zitieren

APA

Hale, M. A., Bates, K., Provenzano, M., & Johnson, N. E. (2023). Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac254

Vancouver

Hale MA, Bates K, Provenzano M, Johnson NE. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac254

BibTeX
@article{Hale2023,
  author = {Hale, Melissa A and Bates, Kameron and Provenzano, Marina and Johnson, Nicholas E},
  title = {Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development},
  journal = {Human Molecular Genetics},
  year = {2023},
  doi = {10.1093/hmg/ddac254}
}
Kostenlos starten →